LO-016 The multifaceted immunomodulatory properties of cenerimod, a selective S1P1 receptor modulator, target three key aspects of SLE pathogenesis

• Peter Cornelisse,
• Daniel S Strasser,
• Marianne M Martinic,
• Mark J Murphy,
• Ouali Berkani,
• Clélia Cahuzac,
• Thomas F Hoyler

Affiliations

Peter Cornelisse

4Biometry, Idorsia Pharmaceuticals Ltd., Switzerland

Daniel S Strasser

2Translational Biomarker, Idorsia Pharmaceuticals Ltd., Switzerland

Marianne M Martinic

1Immunology Pharmacology, Idorsia Pharmaceuticals Ltd., Switzerland

Mark J Murphy

5Immunology Biology, Idorsia Pharmaceuticals Ltd., Switzerland

Ouali Berkani

3Clinical Science, Idorsia Pharmaceuticals Ltd., Switzerland

Clélia Cahuzac

4Biometry, Idorsia Pharmaceuticals Ltd., Switzerland

Thomas F Hoyler

1Immunology Pharmacology, Idorsia Pharmaceuticals Ltd., Switzerland